News

DUAL completes acquisition of David Ashby Underwriting, enhancing capabilities in the equestrian sector

Published

DUAL today announced the acquisition of David Ashby Underwriting Limited (“DAU”), a leading MGA specialising in bloodstock and High Value Sports Horse insurance. This acquisition cements DUAL as a leader in the bloodstock underwriting arena, providing insurance solutions across multiple territories.

DAU was formed in 2020 following David Ashby’s acquisition of Amlin’s bloodstock and livestock book, supported by Blunt Palmer Brown Ventures (“BPB”).  It provides cover in Thoroughbred bloodstock, commercial breeding, rearing and racing, and High Value Sports Horses. DAU’s team of ten, including eight underwriters, will join DUAL with immediate effect.

David Howden, CEO, Howden, said: “Joining with David and his expert team deepens our connection to the equestrian world, and makes us a true differentiator in this exciting market. DUAL now provides world-class expertise in all the major equine markets, and we will continue to leverage our expertise to provide more choice and a fresh alternative for clients.”

Richard Clapham, CEO, DUAL Group, said: “David Ashby has a long-standing reputation for excellence and they bring a real passion for the equestrian sector. We are delighted to welcome them to DUAL. This positions DUAL as one of the London Market’s leading bloodstock underwriters, and we look forward to seeing David build on Ashby’s existing business, as well as identifying new opportunities to grow.” 

David Ashby added: “We are excited to join DUAL. Not only are they one of the largest and most diverse MGAs in the world, they also share our focus on excellence in underwriting. We did not choose our future home lightly and I am looking forward to working with Richard and the DUAL team.”

Jonathan Palmer Brown of BPB said: “The Board is very grateful for David and his team’s hard work and we wish them all the best in their future at DUAL. We have enjoyed working together and are happy they are joining a firm with such a strong commitment to Bloodstock “